Universal CLL1 car-T

Clinical trials for Universal CLL1 car-T explained in plain language.

Never miss a new study

Get alerted when new Universal CLL1 car-T trials appear

Sign up with your email to follow new studies for Universal CLL1 car-T, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Off-the-Shelf cell therapy takes on tough leukemia

Disease control Not yet recruiting

This early-stage study tests a new type of CAR-T cell therapy for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses donor cells engineered to target a protein called CLL1 found on most AML cells, and is designed …

Matched conditions: UNIVERSAL CLL1 CAR-T

Phase 1 • Sponsor: Mingfeng Zhao • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC

Universal CLL1 car-T

Get alerted when new Universal CLL1 car-T trials appear

Off-the-Shelf cell therapy takes on tough leukemia